{"text": "$gild #gilead sciences, inc. gilead presents new phase 2 data on bictegravir, an... URL #news URL"}
{"text": "$gild ph 2 trial in hiv with bictegravir - 97% patients had undetectable levels at 24 and 48 weeks. (1/2)"}
{"text": "rt AT_USER $gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to doluteg\u00a1\u00ad"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER $gild press release with bictegravir ph2 data coming tonight, after croi media briefing ends."}
{"text": "rt AT_USER $gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to doluteg\u00a1\u00ad"}
{"text": "want the latest upgrades &amp; downgrades for $atml $tlab $keyn $nmm $gild? checkout marketbeat daily URL"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER $gild press release with bictegravir ph2 data coming tonight, after croi media briefing ends."}
{"text": "$gild gilead presents new phase 2 data on bictegravir, an investigational integrase strand transfer inhibi... - URL"}
{"text": "$gild gilead announces findings from new preclinical study evaluating novel class of hiv capsid inhibitors... - URL"}
{"text": "$gild URL"}
{"text": "$gild announces findings from new preclinical study evaluating novel class of hiv capsid inhibitors that support c\u00a1\u00ad URL"}
{"text": "rt AT_USER $gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to doluteg\u00a1\u00ad"}
{"text": "rt AT_USER $gild press release with bictegravir ph2 data coming tonight, after croi media briefing ends."}
{"text": "rt AT_USER $gild press release with bictegravir ph2 data coming tonight, after croi media briefing ends."}
{"text": "rt AT_USER $gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to doluteg\u00a1\u00ad"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER some nice news for $gild .... at this price i wouldn't bet against these guys...... URL"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "$gild - gilead presents new phase 2 data on bictegravir, an investigational integrase strand transfer inhibitor URL"}
{"text": "$gild - gilead announces findings from new preclinical study evaluating novel class of hiv capsid inhibitors URL"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER $gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to doluteg\u00a1\u00ad"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER $gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to doluteg\u00a1\u00ad"}
{"text": "rt AT_USER $gild press release with bictegravir ph2 data coming tonight, after croi media briefing ends."}
{"text": "rt AT_USER $gild press release with bictegravir ph2 data coming tonight, after croi media briefing ends."}
{"text": "rt AT_USER $gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to doluteg\u00a1\u00ad"}
{"text": "some nice news for $gild .... at this price i wouldn't bet against these guys...... URL"}
{"text": "$gild in play tomorrow. URL"}
{"text": "$gild press release with bictegravir ph2 data coming tonight, after croi media briefing ends. AT_USER URL"}
{"text": "$gild press release with bictegravir ph2 data coming tonight, after croi media briefing ends."}
{"text": "rt AT_USER $gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to doluteg\u00a1\u00ad"}
{"text": "$gild #blessed !! URL"}
{"text": "$gild - detailed presentation of bictegravir data tomorrow, but these top-line results, numerically superior to dolutegravir, look good."}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "rt AT_USER $gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks a\u00a1\u00ad"}
{"text": "$gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolute AT_USER URL"}
{"text": "$gild hiv ph2 data from croi \u00a1\u00aa bictegravir 97% \u00a1\u00b0undetectable\u00a1\u00b1 at 24 wks and 48wks vs. $gsk dolutegravir 94% at 24 wks and 91% at 48 wks."}
{"text": "AT_USER after some research... maybe you're on to something. $gild too cheap"}
{"text": "good timing, needed this about right now on mpns: review series - february 9, 2017 | blood journal $incy $gild URL"}
{"text": "$ibb took next weeks $280/$275 bull put spread. c'mon get through resistance tmoz. $celg $regn $biib $gild #options URL"}
{"text": "$gild up 1.94%. interesting 3 times more calls than puts on options today. URL"}
{"text": "AT_USER $gild optimism? tom price was confirmed yesterday.  way too much uncertainty.  a crazy idea."}
{"text": "AT_USER all ready %100 $gild"}
{"text": "AT_USER look at components.. $regn beat me to be back.. $gild $celg need good days, $biib also ."}
{"text": "9 top pharmaceutical stocks to buy for the dividends $abbv $gsk $teva $sny $azn $pfe $gild $nvo $pdli URL"}
{"text": "$gild $sino $glbs all $1 moves from chat ideas and $myos also a big mover today. #mondaymorning #money #stocks URL"}
{"text": "$rnn rallying 12% after hours !!!. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
{"text": "ttg themes of the day (below) &amp; option summary: $aapl $fb $mos $cf $vale $cien $ocrl $adsk $gild $xlv $xrt $xlu URL"}
{"text": "$rnn rallying 10% after hours !!!. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
{"text": "pharma m&amp;a in 2017: the most likely deal hunters URL $amgn $gild $mrk $pfe $pbyi $cara $bmrn"}
{"text": "pharma m&amp;a in 2017: the most likely deal hunters URL $amgn $gild $mrk $pfe $bmrn $jazz $cara $adpt"}
{"text": "#gileadsciences cytodyn inc. : (cydy) pro 140 - a promising entry in the treatment of hiv. read more: URL $gild"}
{"text": "#gileadsciences forget gilead, buy these 5 biotech stocks instead. read more: URL $gild"}
{"text": "real portfolio: $gild $aapl $cara $zyne $gwph lead to 40% monthly yield URL URL"}
{"text": "AT_USER when are you going to get long $gild ?? #doyoulikemoney"}
{"text": "i think teva will buyout $cvm !!!. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
{"text": "$cvm met with #fda about path towards removal of hold !!!. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
{"text": "AT_USER AT_USER AT_USER lol $gild... or $drys if you're willing to gamble :)  you know there's a huge pop there coming up"}
{"text": "AT_USER AT_USER AT_USER $yelp $fit or $gild ? which of the beaten should i bite into ? thinking $gild"}
{"text": "$gild has had a tremendous bounce following poor earnings. big test will be if it gets back to $73.00"}
{"text": "$rnn rallying 45% fund buys 10 million shares!!!!. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
{"text": "rt AT_USER all signs have gilead $gild gearing up for a much-needed acquisition URL URL"}
{"text": "$rnn rallying 40% fund buys 10 million shares!!!!. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs URL"}
{"text": "fack it, i bought $gild here.  back above tl, os, stop set at 65.10.  swing to long, long if i am up alot lol URL"}
{"text": "$rnn rallying 40% this small biotech has huge upside potential with this amazing pipeline. $gild $incy $bmrn $cldx\u00a1\u00ad URL"}
{"text": "all signs have gilead $gild gearing up for a much-needed acquisition URL URL"}
{"text": "bought $gild calls - april $67.50 for $2.18."}
{"text": "$gild risk reversal trades 2,500 times URL URL"}
{"text": "#gileadsciences can gilead swivel to hiv amid floundering hep c sales, gsk rivalry?. read more: URL $gild"}
{"text": "#gileadsciences selcia limited, cypralis and gilead publish synthetic macrocyclic cyclophil... read more: URL $gild"}
{"text": "better buy: illumina or #gileadsciences?. read more: URL $gild"}
{"text": "$gild has had a tremendous bounce following poor earnings. big test will be if it gets back to $73.00. #verifiedpro URL"}
{"text": "AT_USER AT_USER we need cupid to fire an arrow into $gild's arse"}
{"text": "can gilead swivel to hiv amid flounder hep c sales, gsk rivalry? $gild $gsk URL"}
{"text": "15:04 et volume leader #36 - gild 11,450,751 gilead sciences inc $gild 67.70 +1.34 +2.02% high today of 67.78  URL"}
{"text": "$vix $tlt $ibb $gild $spy $iwm $qqq $aapl $amzn $fb $nflx $tsla $nvda $jpm $wfm $rh $skx URL"}
{"text": "hey how did my $x $40c hit $1.75 w/o me? and my $gild $67.50c spike to $2.64? and there is no way to grab it unless sitting on it. not fair."}
{"text": "that bottom fishing worked out so far in $qcom $gild $ge that i decided to add $twtr.  wish me luck. URL"}
{"text": "AT_USER yes. been looking at $gild almost a year now. looking forward to the 10k. as a value guy, like valuation/insider ownership"}
{"text": "rt AT_USER $gild feb iv ramping w/ 3k feb $66 calls active"}
{"text": "AT_USER thoughts on $ibb at critical pivot point and $gild making a start at filling er gap"}
{"text": "notable monday option activity: $gs $gild $de #stockoptions URL"}
{"text": "i've been eating it on $teva for a few weeks now, just happy their er wasn't the nail in the coffin like $gild URL"}
{"text": "been in $pg $gild $yum calls since this morning. airlines look good as well. kicking myself for not getting in $luv this am. was watching it"}
{"text": "$abbv, $celg, and $jazz $gild $bmy whatever u people do never listen to fools brother. ignore their post. URL"}
{"text": "$gild tiny resistance here at $67.89. next levels. $70.17, $76.08 then $82.77."}
{"text": "$gild \"comfortable that from asset standpt could support any type of acquisition we'd need to do to support growth\" URL"}
{"text": "$heb rallying 20% this small biotech has huge upside potential with this amazing pipeline. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
{"text": "rt AT_USER performance since jul 20, 2015 (not dividend adjusted). AT_USER #zzporte  $alxn $amgn $biib $celg $gild $ibb $qq\u00a1\u00ad"}
{"text": "$gild : may 72.5/77.5 cs bot to open 10000x for about $0.90; total call volume for the day more than 2x 20d avg."}
{"text": "$heb rallying this small biotech has huge upside potential with this amazing pipeline. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
{"text": "$rnn rallying 40% this small biotech has huge upside potential with this amazing pipeline. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
{"text": "rt AT_USER ttg midday activity: $aapl $yum $gild $cf $mos $cien $clf $orcl $crm $srpt URL"}
{"text": "$rnn rallying 35% this small biotech has huge upside potential with this amazing pipeline. $gild $incy $bmrn $cldx $biib $amgn $alxn  $aezs"}
